US equities |
NVDA $204.64 ▼-4.22% INTC $65.76 ▼-28.58% MU $884.74 ▼-5.30% AMZN $240.35 ▼-1.41% AAPL $344.63 ▼-1.23% SNDK $1,150.89 ▼-13.47% AMD $504.80 ▼-10.88% MSFT $521.91 ▼-1.55%
FinancialContent

Dyadic International, Inc. - Common Stock (NQ:DYAI)

0.3802 +0.0192 (+5.32%)
Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dyadic International, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Dyadic International, Inc. Announces Strategic Rebrand to Dyadic Applied BioSolutions
From Dyadic Applied BioSolutions
Via Business Wire
News headline image
Dyadic Announces Leadership Change as Part of Ongoing Strategic Shift to Focus on High Demand Ancillary Proteins for Life Sciences, Nutrition, and Industrial Applications
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
News headline image
Exploring Dyadic International's Earnings Expectations ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 14, 2025 ↗
 
Via Benzinga
News headline image
Dyadic to Present at World Vaccine Congress | Washington
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Power Nickel (TSX.V: PNPN) – Undervalued Precious, Battery, Energy and Base Metals Play Amidst Gold Surge – More Stocks Inside
Via AB Newswire
News headline image
Earnings Scheduled For March 26, 2025 ↗
 
Via Benzinga
News headline image
Breakthroughs and Discoveries: TNON, PNPN.V, POAI, DYAI, PRSO, Drive Innovation Across Sectors
Via AB Newswire
Topics Artificial Intelligence
News headline image
Dyadic (NASDAQ: DYAI) Secures $3M Gates Foundation Grant to Advance Global Vaccines & Therapeutics with C1 Fungal Platform – More Stocks Inside
Via AB Newswire
News headline image
Dyadic Announces Funding Award from CEPI to Use C1 to Accelerate Development of Protein-Based Vaccines
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Dyadic to Report 2024 Full Year Financial Results and Host Conference call on Wednesday, March 26, 2025
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Attend Multiple Industry Events in March
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Provides Business Update; Dyadic to Attend the 43rd Annual J.P. Morgan Healthcare Conference
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology
Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics 
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Expands Global Presence with Participation in Key Industry Events
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
Dyadic Provides Alternative Proteins Business Update and Announces Attendance at Bioprocess International Conference
From Dyadic International, Inc.
Via GlobeNewswire
News headline image
DYAI Stock Earnings: Dyadic International Misses EPS, Misses Revenue for Q2 2024 ↗
DYAI stock results show that Dyadic International missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
SmallCap Tech/Biotech Stocks July/Aug 2024: ZVSA, DYAI, ZVRA, PRSO, RLMD, VTAK, ENTO, INBS, KAVL
Via AB Newswire
Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS
Via AB Newswire
Dyadic Intl (NASDAQ: DYAI) and Proliant Health Biologicals to Launch $6 Billion Serum Albumin Market Product in 2025
Via AB Newswire
Topics Supply Chain
News headline image
Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership
From Dyadic International, Inc.
Via GlobeNewswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Rises in After-Hours Trading Following Major UK Contracts and FDA Progress
Via AB Newswire
Topics Economy
GameStop Raises $2.14 Billion, Meme Stocks Buzz Fuels Gains Watch: GME, PRSO, DYAI, VTAK, AMC
Via AB Newswire
Spotlight June 2024: NASDAQ Stocks Under $2 Achieving Major Milestones TELL, DYAI, PRSO, SPEC, GME
Via AB Newswire
Topics Energy
Meme Stocks Surge Led by ‘Roaring Kitty’ and Social Media Buzz on Reddit (NYSE: RDDT), GME, DYAI, AMC, PRSO, NVAX
Via AB Newswire
Dyadic International Inc. (NASDAQ: DYAI) Hits New 52-Week High Amidst Golden Cross, Bullish Swing Patterns and Bird Flu Concerns
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >